{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:06:37Z","timestamp":1773871597505,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T00:00:00Z","timestamp":1516838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81170355 and 81370592"],"award-info":[{"award-number":["81170355 and 81370592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical Research Center, Shanghai Jiao Tong University School of Medicine."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189888","type":"journal-article","created":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T18:30:56Z","timestamp":1516905056000},"page":"e0189888","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Meta-analysis: High-dose vs. low-dose metronidazole-containing therapies for Helicobacter pylori eradication treatment"],"prefix":"10.1371","volume":"13","author":[{"given":"Yingjie","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-1053","authenticated-orcid":true,"given":"Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00365529509093298","article-title":"The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?","volume":"30","author":"WA De Boer","year":"1995","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/fmb.10.25","article-title":"Helicobacter pylori eradication therapy","volume":"5","author":"H Suzuki","year":"2010","journal-title":"Future microbiology"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"P Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/JCM.00740-07","article-title":"Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005","volume":"45","author":"I Kobayashi","year":"2007","journal-title":"Journal of clinical microbiology"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/hel.12031","article-title":"Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012","volume":"18","author":"JW Lee","year":"2013","journal-title":"Helicobacter"},{"issue":"1","key":"ref6","first-page":"2","article-title":"Helicobacter pylori in Iran: A systematic review on the antibiotic resistance","volume":"18","author":"F Khademi","year":"2015","journal-title":"Iranian journal of basic medical sciences"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000369898","article-title":"The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece","volume":"90","author":"GP Karamanolis","year":"2014","journal-title":"Digestion"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"F Megraud","year":"2013","journal-title":"Gut"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/23744235.2015.1082035","article-title":"Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria","volume":"48","author":"L Boyanova","year":"2016","journal-title":"Infectious diseases (London, England)"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.cgh.2015.02.005","article-title":"Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans","volume":"13","author":"S Shiota","year":"2015","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/1751-2980.12034","article-title":"Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection","volume":"14","author":"WZ Liu","year":"2013","journal-title":"Journal of digestive diseases"},{"issue":"12","key":"ref12","first-page":"Cd008337","article-title":"Optimum duration of regimens for Helicobacter pylori eradication","author":"Y Yuan","year":"2013","journal-title":"The Cochrane database of systematic reviews"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/apt.13495","article-title":"Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection","volume":"43","author":"JM Liou","year":"2016","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1365-2036.2008.03807.x","article-title":"Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication","volume":"28","author":"A Villoria","year":"2008","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12876-016-0491-7","article-title":"Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis","volume":"16","author":"Y Xin","year":"2016","journal-title":"BMC gastroenterology"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"e2750","DOI":"10.1097\/MD.0000000000002750","article-title":"Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis","volume":"95","author":"H Chen","year":"2016","journal-title":"Medicine"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2009.508","article-title":"Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability","volume":"105","author":"J Luther","year":"2010","journal-title":"The American journal of gastroenterology"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1517\/14656566.2013.782286","article-title":"A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication)","volume":"14","author":"AC Marin","year":"2013","journal-title":"Expert opinion on pharmacotherapy"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00042737-199907000-00004","article-title":"Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains","volume":"11","author":"HS Roghani","year":"1999","journal-title":"European journal of gastroenterology & hepatology"},{"issue":"4","key":"ref20","first-page":"154","article-title":"Triple therapy using two dosages of metronidazole along with amoxicillin and omeprazole to eradicate Helicobacter pylori infection: a randomized, open study","volume":"23","author":"E Fattahi","year":"2004","journal-title":"Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1523-5378.2000.00030.x","article-title":"The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection","volume":"5","author":"K Bardhan","year":"2000","journal-title":"Helicobacter"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1523-5378.2006.00394.x","article-title":"Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area","volume":"11","author":"T Matsuhisa","year":"2006","journal-title":"Helicobacter"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1523-5378.1997.tb00051.x","article-title":"Time of Helicobacter pylori eradication assessment following treatment","volume":"2","author":"GA Neil","year":"1997","journal-title":"Helicobacter"},{"issue":"4","key":"ref24","first-page":"169","article-title":"Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis","volume":"21","author":"A Srivastava","year":"2002","journal-title":"Indian journal of gastroenterology: official journal of the Indian Society of Gastroenterology"},{"issue":"7414","key":"ref25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1155\/2001\/305756","article-title":"Bismuth-based quadruple therapy with bismuth subcitrate, metronidazole, tetracycline and omeprazole in the eradication of Helicobacter pylori","volume":"15","author":"R Lahaie","year":"2001","journal-title":"Canadian journal of gastroenterology = Journal canadien de gastroenterologie"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/apt.12329","article-title":"Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication","volume":"37","author":"F Sierra","year":"2013","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2036.2012.05137.x","article-title":"High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates","volume":"36","author":"J Sanchez-Delgado","year":"2012","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"Suppl 3","key":"ref29","first-page":"143","article-title":"Guidelines in the medical treatment of Helicobacter pylori infection","volume":"57","author":"J Dzieniszewski","year":"2006","journal-title":"Journal of physiology and pharmacology: an official journal of the Polish Physiological Society"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00535-004-1424-8","article-title":"Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population","volume":"39","author":"T Shimoyama","year":"2004","journal-title":"Journal of gastroenterology"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1523-5378.2003.00150.x","article-title":"Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen","volume":"8","author":"MP Dore","year":"2003","journal-title":"Helicobacter"},{"issue":"1027","key":"ref32","first-page":"290","article-title":"An audit of low dose triple therapy for eradication of Helicobacter pylori","volume":"109","author":"AG Fraser","year":"1996","journal-title":"The New Zealand medical journal"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1046\/j.1365-2036.1999.00606.x","article-title":"Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection","volume":"13","author":"E Bayerdorffer","year":"1999","journal-title":"Alimentary pharmacology & therapeutics"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0188-0128(98)00009-8","article-title":"Three treatment schemes with colloidal bismuth subcitrate (Q-ULCER) in peptic ulcer with Helicobacter pylori","volume":"30","author":"MS Suarez","year":"1999","journal-title":"Archives of medical research"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.dld.2014.07.018","article-title":"A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication","volume":"46","author":"J Heo","year":"2014","journal-title":"Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"ref36","unstructured":"Matougui N, Boudjella ML, Mouffok F, Bouhadef A, Guechi Z, Bouzid K, et al., editors. H. pylori Eradication by Four Triple Therapies: Randomized Study in Double-Blind. International Workshop on Helicobacter and Related Bacteria in; 2009."},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1523-5378.2003.00158.x","article-title":"A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin","volume":"8","author":"S Miehlke","year":"2003","journal-title":"Helicobacter"},{"key":"ref38","article-title":"THE LOW DOSE ANTIBACTERIAL TREATMENT OF HELICOBACTER PYLORI (HP) INFECTION FOR PEPTIC ULCER","volume":"60","author":"K Nambu","year":"2000","journal-title":"Journal of the Showa University Society"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/2050640614530919","article-title":"Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection","volume":"2","author":"AI Sharara","year":"2014","journal-title":"United European gastroenterology journal"},{"issue":"1","key":"ref40","first-page":"33","article-title":"Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori","volume":"89","author":"TJ Borody","year":"1994","journal-title":"The American journal of gastroenterology"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCG.0000000000000165","article-title":"Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan","volume":"49","author":"T Nishizawa","year":"2015","journal-title":"Journal of clinical gastroenterology"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/00365521.2015.1092577","article-title":"In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy","volume":"51","author":"M Di Giulio","year":"2016","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1055\/s-0042-121899","article-title":"Patients with ultrasound diagnosis of hepatic steatosis are at high metabolic risk","volume":"54","author":"J Kalsch","year":"2016","journal-title":"Zeitschrift fur Gastroenterologie"},{"issue":"8","key":"ref44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1157\/13078424","article-title":"[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]","volume":"125","author":"JP Gisbert","year":"2005","journal-title":"Medicina clinica"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1440-1746.2009.05982.x","article-title":"Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection","volume":"24","author":"KM Fock","year":"2009","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/hel.12046","article-title":"Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China","volume":"18","author":"P Su","year":"2013","journal-title":"Helicobacter"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0016-5085(98)70100-3","article-title":"Antibiotic resistance in Helicobacter pylori: implications for therapy","volume":"115","author":"DY Graham","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"ref48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/adc.84.5.419","article-title":"Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome","volume":"84","author":"ME Street","year":"2001","journal-title":"Archives of disease in childhood"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/MPG.0b013e318229c769","article-title":"Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children","volume":"53","author":"P Bontems","year":"2011","journal-title":"Journal of pediatric gastroenterology and nutrition"},{"issue":"18","key":"ref50","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.3748\/wjg.v20.i18.5252","article-title":"Attempts to enhance the eradication rate of Helicobacter pylori infection","volume":"20","author":"CS Bang","year":"2014","journal-title":"World journal of gastroenterology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T19:06:12Z","timestamp":1719774372000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189888"}},"subtitle":[],"editor":[{"given":"John","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189888","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]}}}